Seizures in HIV/AIDS: a southern African perspective

Area of Science:

• Neurology
• Infectious Diseases
• Pharmacology

Background:

• South Africa has a high prevalence of human immunodeficiency virus (HIV), with over 5 million infected individuals.
• Neurologic disease affects over 70% of HIV-infected patients, and new-onset seizures occur in 3-11% of this population.
• Seizure causes in HIV patients include opportunistic infections, HIV itself, neoplasia, cerebrovascular disease, drug toxicity, and metabolic issues, with opportunistic infections being most common in developing countries.

Purpose of the Study:

• To review the causes and management challenges of seizures in human immunodeficiency virus (HIV)-positive patients, particularly in resource-limited settings.
• To highlight the complexities of drug-disease and drug-drug interactions in managing epilepsy in HIV-infected individuals.

Main Methods:

• Literature review focusing on seizure etiologies and management strategies in HIV-positive patients.
• Analysis of drug interactions between antiepileptic drugs (AEDs) and antiretroviral therapy (ART).

Main Results:

• Opportunistic infections are a primary cause of seizures in HIV patients in developing countries.
• Management of seizures in HIV-positive individuals is complicated by potential drug-disease and drug-drug interactions.
• Older antiepileptic drugs (AEDs) rely heavily on the cytochrome P450 system for metabolism, posing interaction risks.
• Newer AEDs may offer a safer alternative for patients on antiretroviral drugs but are often prohibitively expensive.

Conclusions:

• Seizure management in HIV-positive patients requires careful consideration of drug interactions, especially in developing countries.
• The high cost of newer, potentially safer antiepileptic drugs presents a significant barrier to effective epilepsy management in resource-limited settings.
• Further research into cost-effective and safe seizure management strategies for HIV-positive individuals is warranted.